fashion -WSS

fashion

author：entertainment 2025-10-08 16:06:40 - browse：4684

research funding, medical devices — APStock

WASHINGTON — A federal district judge on Monday granted the Biden administration’s request to dismiss a lawsuit challenging Medicare’s new drug price negotiation program from the drug industry lobbying organization PhRMA.

The move is an early but positive sign for the Biden administration in a legal fight that could stretch for years, as a host of major drugmakers, including Merck, Bristol Myers Squibb, and Johnson & Johnson, have also filed lawsuits over the constitutionality of Medicare’s new powers. The first round of drug negotiations is ongoing, and a judge heard oral arguments in a challenge brought by AstraZeneca just last month.

Newsletters

Sign up for D.C. Diagnosis

Washington never stops. Cut through the noise with our essential updates on health care politics and policy

Please enter a valid email address. Privacy Policy

The National Infusion Center Association and the Global Colon Cancer Association are also plaintiffs in PhRMA’s lawsuit. The judge dismissed the National Infusion Center Association from the case because it did not have subject matter jurisdiction to bring the lawsuit. And because NICA was the only party to the lawsuit that resides in Texas, the judge tossed out the case in its entirety.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Free medical tuition alone isn't enough to close gaps in primary care

WSS

Listen: Biogen's potential pivot, & Illumina's next chapter

ALS advocates say criticism of new drugs misses bigger picture

As H5N1 spreads in cows, experts warn against drinking raw milk

The (many) problems with a new study criticizing cancer screening

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

What drug price negotiations mean for Medicare Part D

hotspot

fashion

Sign up for D.C. Diagnosis

focus

Malaria cases in Florida and Texas: Here’s what you need to know

Amazon on where the company's health care bets are headed next

Peter Hotez and the public health issue of online harassment

Lilly’s weekly insulin works as well as daily products, new studies show

Sports medicine is finally prioritizing gender equality

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

How to save PrEP access — and even expand it

How to fix cancer clinical trials' diversity problem

Medical leaders decry Supreme Court decision on affirmative action

How to fix cancer clinical trials' diversity problem

entertainment

House transparency, PBM reform bill gains bipartisan support

What American doctors can learn from their Israeli counterparts

Covid hospitalizations on the rise, Humana says

Stem cell treatment guidelines are released by FDA

How to fix cancer clinical trials' diversity problem

What drug price negotiations mean for Medicare Part D

focus

knowledge

focus

hotspot